SAM
EW icon

SEB Asset Management’s Edwards Lifesciences EW Stock Holding History

SEB Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107M Sell
1,182,636
-187,566
-14% -$15.7M 0.4% 40
2026
Q1 		$110M Buy
+1,370,202
New +$113M 0.47% 36

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

SEB Asset Management's EW Position: Q2 2026 in Review

SEB Asset Management reduced its Edwards Lifesciences (EW) stake by 14% in Q2 2026, selling an estimated $15.7M and leaving 1,182,636 shares worth $107M. The position accounts for 0.4% of the portfolio, ranked #40.

SEB Asset Management first reported a position in EW in Q1 2026 and has held it in 2 quarters since. The position peaked at $110M in Q1 2026. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • SEB Asset Management held 1,182,636 shares of Edwards Lifesciences worth $107M as of Q2 2026.
  • SEB Asset Management sold 187,566 Edwards Lifesciences shares in Q2 2026, an estimated $15.7M.
  • Edwards Lifesciences made up 0.4% of SEB Asset Management's portfolio in Q2 2026, its #40 holding.
  • SEB Asset Management first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Edwards Lifesciences position peaked at $110M in Q1 2026.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.